Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma
Protocol for Patients With Newly-Diagnosed Non-Metastatic Osteosarcoma - A POG/CCG Pilot Intergroup Study
5 other identifiers
interventional
253
6 countries
148
Brief Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Chemoprotective drugs such as dexrazoxane may protect normal cells from the side effects of chemotherapy. PURPOSE: Phase III trial to study the effectiveness of three combination chemotherapy regimens plus dexrazoxane in treating patients who have newly diagnosed nonmetastatic osteosarcoma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started Sep 1999
Longer than P75 for phase_3
148 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 1999
CompletedFirst Submitted
Initial submission to the registry
November 1, 1999
CompletedFirst Posted
Study publicly available on registry
February 9, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2008
CompletedAugust 5, 2014
August 1, 2014
4.5 years
November 1, 1999
August 4, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Event Free Survival
Study Arms (3)
Pilot 1 - Doxorubicin Intensification without Ifosfamide
EXPERIMENTALDexrazoxane hydrochloride IV followed by doxorubicin hydrochloride IV plus cisplatin IV on days 1 and 2 of weeks 1 and 6. Methotrexate IV on day 1 of weeks 4, 5, 9, and 10. Patients undergo surgery on week 11. Adjuvant chemotherapy begins on day 1 of week 13. Group 1 (good response to neoadjuvant chemotherapy): Patients receive methotrexate IV over 4 hours every 3 weeks for 6 courses, beginning on week 13. Patients also receive dexrazoxane and doxorubicin hydrochloride every 3 weeks for 4 courses, beginning on week 14. Cisplatin is administered with the first 2 courses of dexrazoxane and doxorubicin. Group 2 (standard response to neoadjuvant chemotherapy): Patients receive methotrexate and cisplatin as in group 1 plus dexrazoxane and doxorubicin hydrochloride for 6 courses.
Pilot 2 - Doxorubicin Intensification with Ifosfamide
EXPERIMENTALPreoperative therapy comprised of dexrazoxane hydrochloride, doxorubicin hydrochloride, and methotrexate as in pilot 1. Ifosfamide IV on days 1-5 of week 1. Patients undergo surgery on week 11, then begin adjuvant chemotherapy on week 13. Group 1: Patients receive methotrexate, dexrazoxane hydrochloride, and doxorubicin hydrochloride as in pilot 1, group 1. Ifosfamide is also administered on weeks 14 and 20. Cisplatin is administered on weeks 17, 23, and 26. Group 2: Patients receive methotrexate, dexrazoxane hydrochloride, and doxorubicin hydrochloride as in pilot 1, group 2. Ifosfamide is administered on weeks 14, 20, 26, and 31. Cisplatin is administered on weeks 17, 23, and 29
Pilot 3 - Ifosfamide/Etoposide Intensification
EXPERIMENTALPreoperative therapy comprised of methotrexate, dexrazoxane hydrochloride, doxorubicin, ifosfamide, and cisplatin as in pilot 2. Patients undergo surgery on week 11, then begin adjuvant chemotherapy on week 13. Group 1: Patients receive methotrexate, dexrazoxane hydrochloride, doxorubicin, ifosfamide, and cisplatin as in pilot 2, group 1. Group 2: Patients receive methotrexate on weeks 13, 19, 29, 32, 35, and 36, high dose ifosfamide and etoposide IV over 4 hours on days 1-5 of weeks 14, 23, and 26, and cisplatin on weeks 20, 30, and 33. Dexrazoxane hydrochloride and doxorubicin hydrochloride are administered on weeks 17, 20, 30, and 33
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Children's Oncology Grouplead
- National Cancer Institute (NCI)collaborator
Study Sites (148)
University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, 35294-3300, United States
MBCCOP - Gulf Coast
Mobile, Alabama, 36688, United States
Arizona Cancer Center
Tucson, Arizona, 85724, United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
University of California San Diego Cancer Center
La Jolla, California, 92093-0658, United States
Long Beach Memorial Medical Center
Long Beach, California, 90806, United States
Children's Hospital Los Angeles
Los Angeles, California, 90027-0700, United States
Jonsson Comprehensive Cancer Center, UCLA
Los Angeles, California, 90095-1781, United States
Children's Hospital of Orange County
Orange, California, 92868, United States
Lucile Packard Children's Hospital at Stanford
Palo Alto, California, 94304, United States
Sutter Cancer Center
Sacramento, California, 95816, United States
University of California Davis Medical Center
Sacramento, California, 95817, United States
Kaiser Permanente-Southern California Permanente Medical Group
San Diego, California, 92120, United States
Children's Hospital and Health Center
San Diego, California, 92123-4282, United States
UCSF Cancer Center and Cancer Research Institute
San Francisco, California, 94143-0128, United States
Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, 95051-5386, United States
David Grant Medical Center
Travis Air Force Base, California, 94535, United States
Children's Hospital of Denver
Denver, Colorado, 80218, United States
Yale Comprehensive Cancer Center
New Haven, Connecticut, 06520-8028, United States
Children's National Medical Center
Washington D.C., District of Columbia, 20010-2970, United States
Walter Reed Army Medical Center
Washington D.C., District of Columbia, 20307-5000, United States
Shands Hospital and Clinics, University of Florida
Gainesville, Florida, 32610-100277, United States
Nemours Children's Clinic
Jacksonville, Florida, 32207, United States
Sylvester Cancer Center, University of Miami
Miami, Florida, 33136, United States
Miami Children's Hospital
Miami, Florida, 33155, United States
Baptist Hospital of Miami
Miami, Florida, 33176-2197, United States
Walt Disney Memorial Cancer Institute
Orlando, Florida, 32803, United States
All Children's Hospital
St. Petersburg, Florida, 33701, United States
CCOP - Florida Pediatric
Tampa, Florida, 33682-7757, United States
St. Mary's Hospital
West Palm Beach, Florida, 33407, United States
Emory University Hospital - Atlanta
Atlanta, Georgia, 30322, United States
Cancer Research Center of Hawaii
Honolulu, Hawaii, 96813, United States
Tripler Army Medical Center
Honolulu, Hawaii, 96859-5000, United States
Rush-Presbyterian-St. Luke's Medical Center
Chicago, Illinois, 60612, United States
Children's Memorial Hospital, Chicago
Chicago, Illinois, 60614, United States
University of Chicago Cancer Research Center
Chicago, Illinois, 60637-1470, United States
Hope Children's Hospital
Oak Lawn, Illinois, 60453, United States
CCOP - Illinois Oncology Research Association
Peoria, Illinois, 61602, United States
Saint Jude Midwest Affiliate
Peoria, Illinois, 61637, United States
Indiana University Cancer Center
Indianapolis, Indiana, 46202-5289, United States
Holden Comprehensive Cancer Center at The University of Iowa
Iowa City, Iowa, 52242-1009, United States
University of Kansas Medical Center
Kansas City, Kansas, 66160-7357, United States
CCOP - Wichita
Wichita, Kansas, 67214-3882, United States
Via Christi Regional Medical Center
Wichita, Kansas, 67214, United States
MBCCOP - LSU Health Sciences Center
New Orleans, Louisiana, 70112, United States
Tulane University School of Medicine
New Orleans, Louisiana, 70112, United States
CCOP - Ochsner
New Orleans, Louisiana, 70121, United States
Eastern Maine Medical Center
Bangor, Maine, 04401, United States
Maine Children's Cancer Program
Portland, Maine, 04101, United States
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
Baltimore, Maryland, 21201, United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21231-2410, United States
Boston Floating Hospital Infants and Children
Boston, Massachusetts, 02111, United States
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, 01655, United States
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109-0752, United States
Children's Hospital of Michigan
Detroit, Michigan, 48201, United States
St. John's Hospital and Medical Center
Detroit, Michigan, 48236, United States
Hurley Medical Center
Flint, Michigan, 48503, United States
CCOP - Kalamazoo
Kalamazoo, Michigan, 49007-3731, United States
University of Minnesota Cancer Center
Minneapolis, Minnesota, 55455, United States
Mayo Clinic Cancer Center
Rochester, Minnesota, 55905, United States
University of Mississippi Medical Center
Jackson, Mississippi, 39216-4505, United States
Keesler Medical Center - Keesler AFB
Keesler Air Force Base, Mississippi, 39534-2576, United States
University of Missouri-Columbia Hospital and Clinics
Columbia, Missouri, 65212, United States
Children's Mercy Hospital
Kansas City, Missouri, 64108, United States
Cardinal Glennon Children's Hospital
St Louis, Missouri, 63104, United States
Washington University School of Medicine
St Louis, Missouri, 63110, United States
University of Nebraska Medical Center
Omaha, Nebraska, 68198-3330, United States
Norris Cotton Cancer Center
Lebanon, New Hampshire, 03756-0002, United States
CCOP - Northern New Jersey
Hackensack, New Jersey, 07601, United States
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
Cancer Institute of New Jersey
New Brunswick, New Jersey, 08901, United States
University of New Mexico School of Medicine
Albuquerque, New Mexico, 87131, United States
Roswell Park Cancer Institute
Buffalo, New York, 14263-0001, United States
Schneider Children's Hospital
New Hyde Park, New York, 11042, United States
NYU School of Medicine's Kaplan Comprehensive Cancer Center
New York, New York, 10016, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, 10021, United States
Mount Sinai School of Medicine
New York, New York, 10029, United States
Herbert Irving Comprehensive Cancer Center
New York, New York, 10032, United States
University of Rochester Cancer Center
Rochester, New York, 14642, United States
State University of New York Health Sciences Center - Stony Brook
Stony Brook, New York, 11790-7775, United States
State University of New York - Upstate Medical University
Syracuse, New York, 13210, United States
Mission Saint Joseph's Health System
Asheville, North Carolina, 28801, United States
Lineberger Comprehensive Cancer Center, UNC
Chapel Hill, North Carolina, 27599-7295, United States
Carolinas Medical Center
Charlotte, North Carolina, 28232-2861, United States
Presbyterian Healthcare
Charlotte, North Carolina, 28233-3549, United States
Duke Comprehensive Cancer Center
Durham, North Carolina, 27710, United States
East Carolina University School of Medicine
Greenville, North Carolina, 27858-4354, United States
Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, 27157-1082, United States
Veterans Affairs Medical Center - Fargo
Fargo, North Dakota, 58102, United States
CCOP - Merit Care Hospital
Fargo, North Dakota, 58122, United States
Children's Hospital Medical Center - Cincinnati
Cincinnati, Ohio, 45229-3039, United States
Ireland Cancer Center
Cleveland, Ohio, 44106-5065, United States
Children's Hospital of Columbus
Columbus, Ohio, 43205-2696, United States
Oklahoma Memorial Hospital
Oklahoma City, Oklahoma, 73126-0307, United States
Natalie Warren Bryant Cancer Center
Tulsa, Oklahoma, 74136, United States
Doernbecher Children's Hospital
Portland, Oregon, 97201-3098, United States
CCOP - Columbia River Program
Portland, Oregon, 97213, United States
Legacy Emanuel Hospital and Health Center
Portland, Oregon, 97227, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
St. Christopher's Hospital for Children
Philadelphia, Pennsylvania, 19134-1095, United States
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
Medical University of South Carolina
Charleston, South Carolina, 29425-0721, United States
Children's Hospital of Greenville Hospital System
Greenville, South Carolina, 29605, United States
James H. Quillen College of Medicine
Johnson City, Tennessee, 37614-0622, United States
Saint Jude Children's Research Hospital
Memphis, Tennessee, 38105-2794, United States
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232-6838, United States
Texas Oncology P.A.
Dallas, Texas, 75230-2503, United States
Medical City Dallas Hospital
Dallas, Texas, 75230, United States
Simmons Cancer Center - Dallas
Dallas, Texas, 75235-9154, United States
University of Texas Medical Branch
Galveston, Texas, 77555-0209, United States
University of Texas - MD Anderson Cancer Center
Houston, Texas, 77030-4009, United States
Baylor College of Medicine
Houston, Texas, 77030, United States
San Antonio Military Pediatric Cancer and Blood Disorders Center
Lackland Air Force Base, Texas, 78236-5300, United States
MBCCOP - South Texas Pediatric
San Antonio, Texas, 78229-3900, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78284-7811, United States
Scott and White Clinic
Temple, Texas, 76508, United States
Vermont Cancer Center
Burlington, Vermont, 05401-3498, United States
Cancer Center at the University of Virginia
Charlottesville, Virginia, 22908, United States
Inova Fairfax Hospital
Falls Church, Virginia, 22042-3300, United States
Naval Medical Center, Portsmouth
Portsmouth, Virginia, 23708-2197, United States
Massey Cancer Center
Richmond, Virginia, 23298-0037, United States
Carilion Roanoke Community Hospital
Roanoke, Virginia, 24029, United States
Children's Hospital and Regional Medical Center - Seattle
Seattle, Washington, 98105, United States
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109-1024, United States
Madigan Army Medical Center
Tacoma, Washington, 98431-5000, United States
West Virginia University Medical School-Charleston
Charleston, West Virginia, 25304, United States
West Virginia University Hospitals
Morgantown, West Virginia, 26506-9300, United States
St. Vincent Hospital
Green Bay, Wisconsin, 54307-3508, United States
University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin, 53792-6164, United States
Midwest Children's Cancer Center
Milwaukee, Wisconsin, 53226, United States
Royal Children's Hospital
Parkville, Victoria, 3052, Australia
Princess Margaret Hospital for Children
Perth, Western Australia, 6001, Australia
Alberta Children's Hospital
Calgary, Alberta, T2T 5C7, Canada
Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2, Canada
British Columbia Children's Hospital
Vancouver, British Columbia, V6H 3V4, Canada
IWK Health Centre
Halifax, Nova Scotia, B3J 3G9, Canada
Children's Hospital
Hamilton, Ontario, L8N 3Z5, Canada
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1, Canada
Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
McGill University Health Center - Montreal Children's Hospital
Montreal, Quebec, H3H 1P3, Canada
Hopital Sainte Justine
Montreal, Quebec, H3T 1C5, Canada
Centre Hospitalier de L'Universite Laval
Sainte-Foy, Quebec, GIV 4G2, Canada
Academisch Ziekenhuis Groningen
Groningen, 9713 EZ, Netherlands
San Jorge Childrens Hospital
Santurce, 00912, Puerto Rico
Swiss Pediatric Oncology Group Bern
Bern, CH 3010, Switzerland
Clinique de Pediatrie
Geneva, 1211, Switzerland
Related Publications (3)
Isakoff MS, Barkauskas DA, Ebb D, Morris C, Letson GD. Poor survival for osteosarcoma of the pelvis: a report from the Children's Oncology Group. Clin Orthop Relat Res. 2012 Jul;470(7):2007-13. doi: 10.1007/s11999-012-2284-9. Epub 2012 Feb 22.
PMID: 22354612BACKGROUNDJaneway KA, Barkauskas DA, Krailo MD, Meyers PA, Schwartz CL, Ebb DH, Seibel NL, Grier HE, Gorlick R, Marina N. Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group. Cancer. 2012 Sep 15;118(18):4597-605. doi: 10.1002/cncr.27414. Epub 2012 Jan 17.
PMID: 22252521BACKGROUNDKopp LM, Womer RB, Schwartz CL, Ebb DH, Franco VI, Hall D, Barkauskas DA, Krailo MD, Grier HE, Meyers PA, Wexler LH, Marina NM, Janeway KA, Gorlick R, Bernstein ML, Lipshultz SE; Children's Oncology Group. Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology Group. Cardiooncology. 2019 Oct 28;5:15. doi: 10.1186/s40959-019-0050-9. eCollection 2019.
PMID: 32154021DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Cindy Schwartz, MD
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 1999
First Posted
February 9, 2004
Study Start
September 1, 1999
Primary Completion
March 1, 2004
Study Completion
June 1, 2008
Last Updated
August 5, 2014
Record last verified: 2014-08